Skip to main content
Clinical Trials/NCT04650139
NCT04650139
Recruiting
Not Applicable

Coronary Interventions Ulm - Coronary Chronic Total Occlusions

University Hospital Ulm1 site in 1 country500 target enrollmentJanuary 1, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Total Occlusion of Coronary Artery
Sponsor
University Hospital Ulm
Enrollment
500
Locations
1
Primary Endpoint
MACE
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

The aim of the proposed project is to provide the long-term results after a recanalization attempt of chronically occluded coronary arteries.

To investigate recanalization attempt of chronically occluded coronary arteries at the Ulm University Hospital. As shown, it is known that successful recanalization of a chronic occlusion is associated with a lower event rate (reduced mortality and the need for operative myocardial revascularization) compared to unsuccessful recanalization (drug therapy). The standard in the therapy of successfully recanalized chronic occlusions is the use of drug-releasing vascular supports.

Registry
clinicaltrials.gov
Start Date
January 1, 2014
End Date
January 1, 2025
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital Ulm
Responsible Party
Principal Investigator
Principal Investigator

Bruno Correia

Investigator

University Hospital Ulm

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years
  • Coronary intervention in chronic coronary artery occlusion
  • Occlusion \> 3 months
  • Indication for PTCA or recanalization according to guidlines
  • Symptoms of the patient
  • Evidence of myocardial ischemia (stress ECG, scintigraphic
  • Methods, magnetic resonance imaging, stress echocardiography)
  • pathological intracoronary flow reserve, prognostic

Exclusion Criteria

  • No chronic occlusion,
  • Contraindication to anti-platelet therapy
  • Acetylsalicylic acid plus clopidogrel for at least 3 months such as e.g.
  • with florid gastrointestinal ulcer disease,
  • History of hemorrhagic stroke
  • or urgent non-postponable surgical intervention.
  • Basic disease with a life expectancy of less than 12 months (here as a rule
  • no indication for PTCA or reopening available)

Outcomes

Primary Outcomes

MACE

Time Frame: 1 year

major adverse cardiac event

Secondary Outcomes

  • TLR(1 year)

Study Sites (1)

Loading locations...

Similar Trials